USPTO issues NOA for Collegium opioid product patent application
The patent entitled, ‘Abuse-Deterrent Drug Formulation’, covers Oxycodone DETERx (COL-003) product which utilizes the company’s proprietary DETERx drug delivery technology. Currently in the final stage of clinical development,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.